Compounds > arg-3-hyp-7-phe-bradykinin
Page last updated: 2024-09-03

arg-3-hyp-7-phe-bradykinin and prostaglandin f1

arg-3-hyp-7-phe-bradykinin has been researched along with prostaglandin f1 in 1 studies

Compound Research Comparison

Studies
(arg-3-hyp-7-phe-bradykinin)		Trials
(arg-3-hyp-7-phe-bradykinin)		Recent Studies (post-2010)
(arg-3-hyp-7-phe-bradykinin)		Studies
(prostaglandin f1)		Trials
(prostaglandin f1)		Recent Studies (post-2010) (prostaglandin f1)
52233181621

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Burch, RM; de Garavilla, L; Kuhn, W; Steranka, LR; Togo, J; Wilson, DD1

Other Studies

1 other study(ies) available for arg-3-hyp-7-phe-bradykinin and prostaglandin f1

ArticleYear
D-Arg-[Hyp3-D-Phe7]-bradykinin, a bradykinin antagonist, reduces mortality in a rat model of endotoxic shock.
    Circulatory shock, 1989, Volume: 27, Issue:2

    Topics: Analgesics; Animals; Bradykinin; Disease Models, Animal; Hemodynamics; Lipopolysaccharides; Male; Prostaglandins F; Radioimmunoassay; Rats; Rats, Inbred Strains; Shock, Septic; Thromboxane B2

1989